Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
69.46
-1.31 (-1.85%)
At close: Mar 28, 2025, 4:00 PM
69.11
-0.35 (-0.50%)
After-hours: Mar 28, 2025, 5:05 PM EDT

Vaxcyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-463.93-402.27-223.49-100.08-89.22
Upgrade
Depreciation & Amortization
15.8510.179.453.461.41
Upgrade
Loss (Gain) From Sale of Assets
---0.10.03
Upgrade
Asset Writedown & Restructuring Costs
----0.27
Upgrade
Loss (Gain) From Sale of Investments
-38.7-34.78-0.951.41-
Upgrade
Stock-Based Compensation
84.8248.7623.6510.735.43
Upgrade
Other Operating Activities
4.23-8-0.18
Upgrade
Change in Accounts Payable
34.5811.232.9-12.4726.1
Upgrade
Change in Other Net Operating Assets
-89.4870.19.84-24.549.17
Upgrade
Operating Cash Flow
-452.63-296.79-170.6-121.39-46.63
Upgrade
Capital Expenditures
-119.16-67.88-5.84-6.56-1.16
Upgrade
Sale of Property, Plant & Equipment
---0.030.05
Upgrade
Investment in Securities
-1,887-705.4380.43-205.78-
Upgrade
Investing Cash Flow
-2,006-773.3174.59-212.31-1.11
Upgrade
Long-Term Debt Repaid
-----0.06
Upgrade
Net Debt Issued (Repaid)
-----0.06
Upgrade
Issuance of Common Stock
2,463643.69862.4117.8268.45
Upgrade
Other Financing Activities
-14.29-3.88-0.86--3.4
Upgrade
Financing Cash Flow
2,449639.81861.5517.8374.87
Upgrade
Foreign Exchange Rate Adjustments
0.43-6.690.14-0.440.09
Upgrade
Net Cash Flow
-9.36-436.97765.67-316.34327.22
Upgrade
Free Cash Flow
-571.79-364.67-176.44-127.95-47.78
Upgrade
Free Cash Flow Per Share
-4.69-3.75-2.72-2.46-1.62
Upgrade
Cash Interest Paid
---0.010.01
Upgrade
Levered Free Cash Flow
-403.44-202.41-107.53-88.16-14.4
Upgrade
Unlevered Free Cash Flow
-403.44-202.41-107.52-88.16-14.39
Upgrade
Change in Net Working Capital
28.99-99.06-10.3731-35.91
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q